A Phase II Trial to Evaluate the Safety and Immunogenicity of Two Doses of a Folate Receptor Alpha Vaccine in Patients with Triple-Negative Breast Cancer.
Saved in:
| Title: | A Phase II Trial to Evaluate the Safety and Immunogenicity of Two Doses of a Folate Receptor Alpha Vaccine in Patients with Triple-Negative Breast Cancer. |
|---|---|
| Authors: | Knutson KL; Department of Immunology, Mayo Clinic, Jacksonville, Florida.; Department of Cancer Biology, Mayo Clinic, Jacksonville, Florida., Abu-Fares H; Department of Immunology, Mayo Clinic, Jacksonville, Florida., Keating P; Department of Biological Sciences, Florida Atlantic University, Boca Raton, Florida., Block MS; Department of Oncology, Mayo Clinic, Rochester, Minnesota.; Department of Immunology, Mayo Clinic, Rochester, Minnesota., Norton N; Department of Cancer Biology, Mayo Clinic, Jacksonville, Florida., Erskine CL; Department of Immunology, Mayo Clinic, Rochester, Minnesota., Cogen D; Department of Immunology, Mayo Clinic, Jacksonville, Florida., Assad H; Karmanos Cancer Institute, Detroit, Michigan., Graff SL; Research Medical Center, Kansas City, Missouri., Hamilton EP; Sarah Cannon Research Institute, Nashville, Tennessee., Han HS; Moffitt Cancer Center, Tampa, Florida., McIntyre KJ; Texas Oncology, Dallas, Texas., Nassar A; Department of Pathology and Laboratory Medicine, Mayo Clinic, Jacksonville, Florida., Sparano JA; Montefiore Medical Center, Bronx, New York., Tiersten A; Mount Sinai Hospital, New York, New York., Tkaczuk KH; University of Maryland, Baltimore, Maryland., Ward PJ; Oncology Hematology Care, Cincinnati, Ohio., Wilson G; TapImmune, Jacksonville, Florida., Garrett G; TapImmune, Jacksonville, Florida.; Marker Therapeutics, Houston, Texas., Kenney RT; TapImmune, Jacksonville, Florida.; Marker Therapeutics, Houston, Texas., Sharma P; University of Kansas Cancer Center, Westwood, Kansas. |
| Source: | Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 Jan 06; Vol. 32 (1), pp. 106-117. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
